苏试试验(300416) - 2017 Q3 - 季度财报

Financial Performance - Operating revenue for the current period reached ¥125,585,875.10, representing a year-on-year increase of 41.14%[7] - Net profit attributable to shareholders was ¥14,617,182.42, up 36.81% from the same period last year[7] - Basic earnings per share rose to ¥0.12, reflecting a 50.00% increase compared to the previous year[7] - Operating profit increased by 32.37% year-on-year, driven by higher revenue and profitability[16] - Net profit for the period was ¥15,723,705.02, up from ¥11,377,023.98 year-over-year, reflecting a growth of approximately 38.5%[33] - Net profit attributable to the parent company was ¥37,738,923.06, a rise of 24.5% from ¥30,296,569.32 in the same period last year[41] - Total comprehensive income for the period was ¥42,429,947.42, compared to ¥34,079,468.72, reflecting an increase of 24.5%[41] Assets and Liabilities - Total assets increased to ¥889,771,525.62, a growth of 16.29% compared to the previous year[7] - Total liabilities increased to ¥282,654,438.81 from ¥211,357,138.02, reflecting a growth of about 33.7%[29] - Current assets totaled ¥415,063,920.33, up from ¥396,116,269.72, indicating a rise of approximately 4.8%[28] - Long-term equity investments rose significantly to ¥184,137,661.92 from ¥111,963,524.92, marking an increase of approximately 64.4%[28] - Expected liabilities increased by 49.11% compared to the beginning of the year, mainly due to an increase in product quality assurance deposits[15] Cash Flow - The net cash flow from operating activities showed a decline, totaling -¥42,517,356.40, down 35.45% year-to-date[7] - The cash inflow from sales of goods and services was CNY 234,711,533.91, an increase of 10.4% compared to CNY 211,915,964.99 in the previous period[47] - The cash flow from operating activities showed a net outflow of CNY -14,938,926.70, an improvement from CNY -45,142,728.91 in the previous period[49] - The company reported a net decrease in cash and cash equivalents of CNY -29,979,647.44, compared to CNY -14,520,449.88 in the previous period[48] Shareholder Information - The company reported a total of 7,600 common shareholders at the end of the reporting period[11] - The largest shareholder, Suzhou Testing Instrument Co., Ltd., holds 47.77% of the shares, totaling 60,000,000 shares[11] - The company did not engage in any repurchase transactions among the top 10 shareholders during the reporting period[12] Revenue and Costs - Revenue increased by 34.48% year-on-year, primarily driven by higher sales of testing equipment and testing services[16] - Total operating revenue for the period reached ¥344,247,983, an increase of 34.4% compared to ¥255,982,602.84 in the previous period[38] - Operating costs amounted to ¥295,883,155.53, up 36.7% from ¥216,543,652.68[38] - Sales expenses increased to ¥29,081,998.11, compared to ¥22,877,703.72, marking a rise of 27.3%[38] - Management expenses rose to ¥66,194,841.90, up from ¥51,348,999.34, an increase of 28.9%[38] Financial Ratios - The weighted average return on net assets was 2.90%, an increase of 0.66% from the previous year[7] - The basic earnings per share improved to ¥0.12 from ¥0.08, representing a 50% increase[33] - Financial expenses surged to ¥2,812,607.06 from ¥491,664.19, indicating a significant increase of 471.5%[38] Inventory and Receivables - Accounts receivable decreased by 31.27% compared to the beginning of the year, mainly due to the endorsement transfer of notes for increased supplier payments[15] - Inventory increased by 38.37% compared to the beginning of the year, attributed to increased sales volume leading to higher input[15] - Other receivables increased by 79.03% compared to the beginning of the year, mainly due to increased advance deposits for bidding projects[15] Asset Disposal - Cash received from the disposal of fixed assets increased by 194,112.91% year-on-year, mainly due to cash received from the disposal of laboratory equipment[16]